Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

Frontiers Choosing a cellular model to study SARS-CoV-2

Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies - Troyer - 2021 - Journal of Extracellular Vesicles - Wiley Online Library

Frontiers Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii

mRNA vaccines for COVID-19: what, why and how

Frontiers Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status

48 Javier Lopez Jr Stock Photos, High-Res Pictures, and Images

Frontiers Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Frontiers Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease

Frontiers Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19

Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19)